Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid
- PMID: 338883
- DOI: 10.1902/jop.1977.48.12.778
Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid
Abstract
1. C3 activation products C3c and C3d can be demonstrated in gingival pocket fluid from patients with severe periodontitis. 2. Quantitatively, C3d levels in GF are comparable to levels attained consequent to immune-complex and tryptic activation of human serum. 3. The alternate pathway of complement activation occurs in the periodontal pocket, as demonstrated by conversion of C3 proactivator (Factor B) to C3-activator Bb. 4. C4 is present in an altered form in some, but not all, GF's. This form is electrophoretically similar to that generated from serum by C1s and several proteolytic enzymes.
Similar articles
-
Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins.J Periodontol. 1977 Dec;48(12):772-7. doi: 10.1902/jop.1977.48.12.772. J Periodontol. 1977. PMID: 73582
-
Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy.J Periodontal Res. 1985 May;20(3):268-75. doi: 10.1111/j.1600-0765.1985.tb00434.x. J Periodontal Res. 1985. PMID: 3160842 No abstract available.
-
Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid. I. Reliability of the method.J Periodontal Res. 1985 May;20(3):260-7. doi: 10.1111/j.1600-0765.1985.tb00433.x. J Periodontal Res. 1985. PMID: 3160841 No abstract available.
-
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review.
-
Complement abnormalities in multiple myeloma.Am J Med. 1989 Oct;87(4):411-20. doi: 10.1016/s0002-9343(89)80824-1. Am J Med. 1989. PMID: 2679074 Review.
Cited by
-
Effect of ozone on periodontopathogenic species--an in vitro study.Clin Oral Investig. 2012 Apr;16(2):537-44. doi: 10.1007/s00784-011-0515-1. Epub 2011 Feb 2. Clin Oral Investig. 2012. PMID: 21287208
-
A pleiotropic role of sialidase in the pathogenicity of Porphyromonas gingivalis.Infect Immun. 2024 Mar 12;92(3):e0034423. doi: 10.1128/iai.00344-23. Epub 2024 Feb 20. Infect Immun. 2024. PMID: 38376159 Free PMC article.
-
Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement.Cell Host Microbe. 2011 Nov 17;10(5):497-506. doi: 10.1016/j.chom.2011.10.006. Epub 2011 Oct 27. Cell Host Microbe. 2011. PMID: 22036469 Free PMC article.
-
Functional and structural analyses reveal that a dual domain sialidase protects bacteria from complement killing through desialylation of complement factors.PLoS Pathog. 2023 Sep 25;19(9):e1011674. doi: 10.1371/journal.ppat.1011674. eCollection 2023 Sep. PLoS Pathog. 2023. PMID: 37747935 Free PMC article.
-
Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates.Mol Ther Methods Clin Dev. 2017 Aug 18;6:207-215. doi: 10.1016/j.omtm.2017.08.001. eCollection 2017 Sep 15. Mol Ther Methods Clin Dev. 2017. PMID: 28879212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous